The store will not work correctly when cookies are disabled.
6-Chloro-N'-(5-chloro-2-hydroxybenzoyl)-2-oxo-2H-chromene-3-carbohydrazide
ID: ALA4568499
PubChem CID: 145999855
Max Phase: Preclinical
Molecular Formula: C17H10Cl2N2O5
Molecular Weight: 393.18
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NNC(=O)c1cc2cc(Cl)ccc2oc1=O)c1cc(Cl)ccc1O
Standard InChI: InChI=1S/C17H10Cl2N2O5/c18-9-2-4-14-8(5-9)6-12(17(25)26-14)16(24)21-20-15(23)11-7-10(19)1-3-13(11)22/h1-7,22H,(H,20,23)(H,21,24)
Standard InChI Key: HZBQVEFZUKLVDD-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
15.8802 -19.6703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8790 -20.4899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5871 -20.8988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5853 -19.2615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2939 -19.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2927 -20.4919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0028 -20.9033 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.7186 -20.4940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7198 -19.6688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0052 -19.2529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4252 -20.9046 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4285 -19.2619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1352 -19.6722 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4305 -18.4447 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.8439 -19.2654 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5506 -19.6757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2594 -19.2688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5486 -20.4929 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.9625 -19.6817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6707 -19.2755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6731 -18.4574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9614 -18.0472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2561 -18.4558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9583 -20.4988 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.9605 -17.2300 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.1724 -19.2619 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
8 11 2 0
9 12 1 0
12 13 1 0
12 14 2 0
13 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
19 24 1 0
22 25 1 0
1 26 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 393.18 | Molecular Weight (Monoisotopic): 391.9967 | AlogP: 2.88 | #Rotatable Bonds: 2 |
Polar Surface Area: 108.64 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.53 | CX Basic pKa: ┄ | CX LogP: 3.38 | CX LogD: 3.14 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.46 | Np Likeness Score: -0.92 |
References
1. Jesumoroti OJ, Faridoon, Mnkandhla D, Isaacs M, Hoppe HC, Klein R.. (2019) Evaluation of novel N'-(3-hydroxybenzoyl)-2-oxo-2H-chromene-3-carbohydrazide derivatives as potential HIV-1 integrase inhibitors., 10 (1): [PMID:30774857] [10.1039/C8MD00328A] |